The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: A series of surgically treated patients at a single institution

Cancer

Volumn 113, Issue 7, 2008, Pages 1657-1665

  Mussi, Chiara ^a   Collini, Paola ^a   Miceli, Rosalba ^a   Barisella, Marta ^a   Mariani, Luigi ^a   Fiore, Marco ^a   Casali, Paolo G ^a   Gronchi, Alessandro ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Dedifferentiation; Liposarcoma; Prognosis; Retroperitoneum; Sarcoma; Surgery; Well differentiated liposarcoma

Indexed keywords

AGED; ARTICLE; CELL DEDIFFERENTIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIPOSARCOMA; MALE; METASTASIS; MIDDLE AGED; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE;

AGED; CELL DEDIFFERENTIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIPOSARCOMA; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 54049085379     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23774     Document Type: Article

References (30)

1. Alvarenga JC, Ball AB, Fischer C, et al. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg. 1991;78:912-916.
2. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery and radiotherapy. Cancer. 2006;106:1610-1616.
3. Dei Tos AP. Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol. 2000;4:252-266.
4. Fabre-Guillevin E, Coindre JM, De Saint Aubain Somerhausen N, et al. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocitomas. Cancer. 2006;106:2725-2732.
5. Fletcher CD, Gustafson P, Ridholm A, et al. Clinico pathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045-3050. (Pubitemid 32565442)
6. Chibon F, Mariani O, Derre J, et al. A subgroup pf malignant fibrous histiocytomas is associated with genetic changes similar to those of well differentiated liposarcoma. Cancer Genet Cytogenet. 2002;139:24-29. (Pubitemid 36120402)
7. Coindre JM, Mariani O, Chibon F, et al. Most malignant histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol. 2003;16:256-262. (Pubitemid 36337432)
8. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcoma: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2454.
9. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-561. (Pubitemid 19116001)
10. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796. (Pubitemid 34111387)
11. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
12. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358-371. (Pubitemid 38174479)
13. Stoeckle E, Coindre JM, Bonvaot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368. (Pubitemid 32664443)
14. Neuhaus SJ, Barry P, Clark MA, et al. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92:246-252. (Pubitemid 40269344)
15. Lewis JJ, Leung DL, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228: 355-365. (Pubitemid 30191698)
16. Raut CP, Pisters PWT. Retroperitoneal Sarcomas; combined-modality treatment approaches. J Surg Oncol. 2006;94:81-87. (Pubitemid 43967728)
17. Casali PG, Picci P. Adjuvant chemotherapy for soft tissue sarcoma. Curr Opin Oncol. 2005;17:361-365. (Pubitemid 40904423)
18. Eilber FC, Brennan MF, Eilber FR, et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg. 2007;246: 105-113. (Pubitemid 47012214)
19. Eilber FC, Eilber FR, Eckard J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686-695.
20. Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: result of the Italian Randomized Cooperative Trial. J Clin Oncol. 2001;19:1238-1247. (Pubitemid 32202526)
21. Kraybill WG, Harris J, Spiro IJ, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol. 2006;24:619-625. (Pubitemid 46630425)
22. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197-203. (Pubitemid 28041599)
23. Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection and intraoperative electron beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003;21:3092-3097. (Pubitemid 46606290)
24. Robertson JM, Sondak VK, Weiss SA, et al. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 1995;31:87-92.
25. Jones JJ, Catton CN, O'Sullivan B, et al. Initial results of a trial of preoperative external beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9:346-354. (Pubitemid 34496722)
26. Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271-281. (Pubitemid 27120195)
27. Hasegawa T, Seki K, Hasegawa F, et al. Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades. A clinicopathologic study of 32 cases. Hum Pathol. 2000;31:717-727. (Pubitemid 30445476)
28. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
29. Lucas DR, Nascimento AG, Sanjay BK, et al. Well differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol. 1994;102:677-683. (Pubitemid 24337565)
30. Rubin BP, Fletcher CDM. The cytogenetics of lipomatous tumours. Histopathology. 1997;30:507-511. (Pubitemid 27254938)